79 Percent of US Biotech Firms Contract With Chinese Firms
A new survey finds almost 80 percent of American biotech companies contract with Chinese firms and decoupling from them could be a long game. Some say switching partners could take up to eight years.
Views expressed in this video are opinions of the host and the guest(s), and do not necessarily reflect the views of NTD.